US Patent application submitted for novel OP Exposure Diagnostic Test. June 23, 2015 • admin • General News, Pharmaceuticals Read More »
Countervail Corporation presents significant results of orally dosed AverTox (galantamine) for improved survival from exposure to lethal levels of soman at the CounterACT Symposium held at the New York Academy of Sciences. June 17, 2015 • admin • Funding, Grants Read More »